Synlogic, Roche in Bowel-Disease Collaboration

By Matt Grossman

Synlogic Inc. and Roche Holding AG will collaborate on research into a treatment for inflammatory bowel disease, Synlogic said Thursday.

Following the research period established by the agreement, Roche will have an exclusive option for a licensing and collaboration agreement for further development and commercialization, according to Synlogic, a Cambridge, Mass. based pharmaceutical company.

Write to Matt Grossman at [e-mail]

(END) Dow Jones Newswires

06-17-21 0756ET